PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands. Electronic address: a.eijkelboom@iknl.nl.\', \'Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands. Electronic address: l.demunck@iknl.nl.\', \'Department of Medical Imaging, Zuyderland Medical Center Sittard-Geleen, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, the Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University, Universiteitssingel 40, 6220 ER Maastricht, the Netherlands. Electronic address: marc.lobbes@mumc.nl.\', \'Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands. Electronic address: C.vanGils@umcutrecht.nl.\', \'Divisions of Diagnostic Oncology and Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. Electronic address: j.wesseling@nki.nl.\', \'Laboratory of Pathology, Karel Lotsyweg 145, 3318 AL Dordrecht, the Netherlands. Electronic address: PWestenend@paldordrecht.nl.\', \'Dutch Breast Cancer Society (BVN), Godebaldkwartier 363, 3511 DT Utrecht, the Netherlands. Electronic address: guerrero@borstkanker.nl.\', \'Department of Radiology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. Electronic address: r.pijnappel@lrcb.nl.\', \'Division of Imaging and Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. Electronic address: H.M.Verkooijen@umcutrecht.nl.\', \'Department for Health Evidence, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands; Dutch Expert Centre for Screening, Wijchenseweg 101, 6538 SW Nijmegen, the Netherlands. Electronic address: Mireille.Broeders@radboudumc.nl.\', \'Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands; Technical Medical Centre, University of Twente, Drienerlolaan 5, 7522 NB Enschede, the Netherlands. Electronic address: s.siesling@iknl.nl.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0091-7435(21)00186-910.1016/j.ypmed.2021.106602
?:hasPublicationType
?:journal
  • Preventive medicine
is ?:pmid of
?:pmid
?:pmid
  • 34217417
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.811
?:rankingScore_hIndex
  • 148
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34217417>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34217417>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all